LONDON, Feb 29 (Reuters) – AstraZeneca said a closely watched experimental cancer drug failed in a clinical trial when used on its own to treat mesothelioma, a rare lung and abdominal cancer, but it…
The post AstraZeneca cancer drug fails in mesothelioma trial appeared first on NASDAQ.